Increased primary non-function in transplanted deceased-donor kidneys flushed with histidine-tryptophan-ketoglutarate solution

American Journal of Transplantation

Volumn 9, Issue 5, 2009, Pages 1055-1062

  Stevens, R B ^a   Skorupa, J Y ^a   Rigley, T H ^a   Yannam, G R ^a   Nielsen, K J ^a   Schriner, M E ^a   Skorupa, A J ^a   Murante, A ^a   Holdaway, E ^a   Wrenshall, L E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Delayed graft function (DGF); HTK solution; Kidney transplantation; Organ preservation; Primary nonfunction

Indexed keywords

CLOTRIMAZOLE; COTRIMOXAZOLE; DAPSONE; DIPHENHYDRAMINE; HISTIDINE TRYPTOPHAN KETOGLUTARATE SOLUTION; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PANEL REACTIVE ANTIBODY; PARACETAMOL; PENTAMIDINE; PREDNISONE; PRESERVATION SOLUTION; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALACICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RACE; SURVIVAL;

EID: 65249096661     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02624.x     Document Type: Article

References (48)

1. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980 28 : 295 302.
2. Gebhard MM, Bretschneider HJ, Gersing E, Preusse CJ, Schnabel PA, Ulbricht LJ. Calcium-free cardioplegia-pro. Eur Heart J 1983 4 (Suppl H 151 160.
3. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006 81 : 480 482.
4. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006.: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.
5. Englesbe MJ, Moyer A, Kim DY et al. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006 82 : 136 139.
6. Roels L, Coosemans W, Donck J et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 1998 66 : 1660 1664.
7. Lynch RJ, Kubus J, Chenault RH, Pelletier SJ, Campbell DA, Englesbe MJ. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008 8 : 567 573.
8. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 1999 14 : 1517 1520.
9. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000 58 : 859 866.
10. Browne BJ, Holt CO, Emovon OE. Delayed graft function may not adversely affect short-term renal allograft outcome. Clin Transplant 2003 17 (Suppl 9 35 38.
11. Hetzel GR, Klein B, Brause M et al. Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int 2002 15 : 10 16.
12. McLaren AJ, Jassem W, Gray DW, Fuggle SV, Welsh KI, Morris PJ. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999 13 : 266 272.
13. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997 63 : 968 974.
14. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI. Delayed graft function after renal transplantation. Transplantation 1998 65 : 219 223.
15. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998 66 : 1697 1701.
16. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996 155 : 1831 1840.
17. Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ. Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant 2002 16 : 425 429.
18. Kyllonen LE, Salmela KT, Eklund BH et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 2000 13 : 122 128.
19. Kyllonen LE, Eklund BH, Pesonen EJ, Salmela KT. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 2007 84 : 75 82.
20. Stevens RB, Mercer DF, Grant WJ et al. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation 2008 85 : 1391 1399.
21. Flechner SM, Goldfarb D, Solez K et al. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation 2007 83 : 883 892.
22. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 2008 22 : 1 15.
23. Feng L, Zhao N, Yao X et al. Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl 2007 13 : 1125 1136.
24. Mangus RS, Fridell JA, Vianna RM et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008 14 : 365 373.
25. Welling TH, Heidt DG, Englesbe MJ et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 2008 14 : 73 80.
26. Alonso D, Dunn TB, Rigley T et al. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008 8 : 1942 1945.
27. Nyberg SL, Matas AJ, Kremers WK et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003 3 : 715 721.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999 130 : 461 470.
29. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002 39 : 920 929.
30. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006 52 : 5 18.
31. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
32. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc 1958 53 : 457.
33. Cox D. Regression models and life-tables. J R Stat Soc (B) 1972 34 : 187.
34. Patel SJ, Duhart BT, Jr., Krauss AG et al. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation 2008 86 : 313 320.
35. Stevens RB. Modern approaches to combining sirolimus with calcineurin inhibitors. Transplant Proc 2008 40 : S21 S24.
36. Straatsburg IH, Abrahamse SL, Song SW, Hartman RJ, Van Gulik TM. Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation 2002 74 : 458 464.
37. Schmitz V, Klawitter J, Bendrick-Peart J et al. Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantation. Eur Surg Res 2006 38 : 388 398.
38. Booster MH, van der Vusse GJ, Wijnen RM, Yin M, Stubenitsky BM, Kootstra G. University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation 1994 58 : 979 984.
39. Semmelmann A, Neeff H, Sommer O, Thomusch O, Hopt UT, von Dobschuetz E. Evaluation of preservation solutions by ESR-spectroscopy: superior effects of University of Wisconsin over Histidine-Tryptophan-Ketoglutarate in reducing renal reactive oxygen species. Kidney Int 2007 71 : 875 881.
40. Land W, Schneeberger H, Schleibner S et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994 57 : 211 217.
41. Radovits T, Lin LN, Zotkina J et al. Endothelial dysfunction after long-term cold storage in HTK organ preservation solutions: effects of iron chelators and N-alpha-acetyl-L-histidine. J Heart Lung Transplant 2008 27 : 208 216.
42. Brasen JH, Nieminen-Kelha M, Markmann D et al. Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants. Kidney Int 2005 67 : 1583 1594.
43. Pedotti P, Cardillo M, Rigotti P et al. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 2004 77 : 1540 1545.
44. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988 45 : 673 676.
45. Groenewoud AF, Thorogood J. The HTK Study Group. Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. Transplant Proc 1993 25 (1 Pt 2 1582 1585.
46. de Boer J, De Meester J, Smits JM et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999 12 : 447 453.
47. Opelz G, Dohler B. Multicenter analysis of kidney preservation. Transplantation 2007 83 : 247 253.
48. Daly PJ, Power RE, Healy DA, Hickey DP, Fitzpatrick JM, Watson RW. Delayed graft function: a dilemma in renal transplantation. BJU Int 2005 96 : 498 501.